Recent Finacing
Recent Raise
Agenovir develops computationally engineered nucleases, including CRISPR/Cas systems, to target and cleave intracellular viral DNA to eliminate persistent viral reservoirs, advancing preclinical candidates from Stanford lab research.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors